Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) SHH

Currency In CNY

AD

Valuation

Market Cap3.88B
Enterprise Value3.69B
P/E Ratio-28.07
PEG Ratio0.21
Price/Sales Ratio4.35
Price/Book Ratio0.91
Enterprise/Revenue4.32
Enterprise/EBITDA-991.14

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.16
Operating Margin-0.16
AD

Management Effectiveness

Return On Assets-0.03
Return On Equity-0.03

Income Statement

Revenue563.14M
Revenue/Share1.96
Gross Profit574.88M
EBITDA203.16M
Net Income143.72M
Diluted EPS0.86

Balance Sheet

Total Cash351.48M
Total Cash/Share2.11
Total Debt179.02M
Total Debt/Equity0.12
Current Ratio3.85
Book Value Per Share9.3

Price History

52-Week Change-67.35
52-Week High26.6
52-Week Low6.91
Moving Average 50 Days8.24
Moving Average 200 Days14.81

Statistics

Average Volume2.72M
Shares Outstanding168.31M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.04
Last Split Factor7:5
Last Split DateJuly 18, 2023
AD